Frontiers in Neuroscience | Neuropharmacology

Review

Published on 16 Feb 2023

Literature review on the interdisciplinary biomarkers of multi-target and multi-time herbal medicine therapy to modulate peripheral systems in cognitive impairment

in Neuropharmacology

Sang-Min Park
Seung Hyun Lee
HuiYan Zhao
Jeongtae Kim
Jae young Jang
Yujin Choi
Soyeon Jeong
Soyeong Son
Kyungsook Jung
Jung-Hee Jang

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1108371

3,194 views
1 citation

Original Research

Published on 16 Feb 2023

Comparison of Yizhiqingxin formula extraction methods and their pharmacodynamic differences

in Neuropharmacology

Wei Wei
Hui Pei
Li-Na Ma
Rui Zheng
Qiao-Yi Huang
Su-rui Chang
Yu Cao
Hao Li

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1097859

2,458 views
1 citation

Original Research

Published on 10 Feb 2023

Behavioral and transcriptomic effects of the cancer treatment tamoxifen in mice

in Neuropharmacology

Elena Galvano
Harshul Pandit
Jordy Sepulveda
Christi Anne S. Ng
Melanie K. Becher
Jeanne S. Mandelblatt
Kathleen Van Dyk
G. William Rebeck

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1068334

4,534 views
2 citations

Hypothesis and Theory

Published on 09 Feb 2023

Restoring the missing person to personalized medicine and precision psychiatry

in Neuropharmacology

Ana Gómez-Carrillo
Vincent Paquin
Guillaume Dumas
Laurence J. Kirmayer

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1041433

8,553 views
32 citations

Hypothesis and Theory

Published on 31 Jan 2023

Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use

in Neuropharmacology

Daniel Perkins
Simon G. D. Ruffell
Kimberley Day
Diego Pinzon Rubiano
Jerome Sarris

Frontiers in Neuroscience

doi 10.3389/fnins.2022.879221

19,997 views
15 citations

Editorial

Published on 26 Jan 2023

Editorial: Neuroprotective mechanisms and translational approaches in the retina

in Neuropharmacology

Afsun Sahin
Markus Tschopp
Cavit Agca

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1140759

1,177 views

Editorial

Published on 25 Jan 2023

Editorial: Beta-Amyloid oligomer specific treatments for Alzheimer's disease

in Neuropharmacology

Heinz Hillen

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1034158

2,215 views
1 citation

Brief Research Report

Published on 24 Jan 2023

Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist-induced dyskinesia via β-arrestin signaling

in Neuropharmacology

Koki Nagaoka
Nozomi Asaoka
Kazuki Nagayasu
Hisashi Shirakawa
Shuji Kaneko

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1082375

2,569 views
8 citations

Original Research

Published on 20 Jan 2023

The efficacy and mechanism of berberine in improving aging-related cognitive dysfunction: A study based on network pharmacology

in Neuropharmacology

Jiuxiu Yao
Wei Wei
Jiayu Wen
Yu Cao
Hao Li

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1093180

8,222 views
13 citations

Review

Published on 19 Jan 2023

Memantine as a neuroprotective agent in ischemic stroke: Preclinical and clinical analysis

in Neuropharmacology

Diego Pichardo-Rojas
Pavel Salvador Pichardo-Rojas
José Manuel Cornejo-Bravo
Aracely Serrano-Medina

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1096372

11,287 views
12 citations

Original Research

Published on 19 Jan 2023

Comparing therapeutic modulators of the SOD1 G93A Amyotrophic Lateral Sclerosis mouse pathophysiology

in Neuropharmacology

Albert J. B. Lee
Tyler E. Kittel
Renaid B. Kim
Thao-Nguyen Bach
Tian Zhang
Cassie S. Mitchell

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1111763

2,998 views
4 citations

Hypothesis and Theory

Published on 17 Jan 2023

Whether ambulatory electroencephalogram and visual tracking system could be the new strategy for pain assessment?

in Neuropharmacology

Xiaqing Ma
Hong Zhang
Tao Xu

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1122614

1,784 views
1 citation

Original Research

Published on 10 Jan 2023

Assessing the role of primary healthy microglia and gap junction blocker in hindering Alzheimer’s disease neuroinflammatory type: Early approaches for therapeutic intervention

in Neuropharmacology

Mai M. Anwar
Esra Özkan
Narges Shomalizadeh
Selin Sapancı
Ceyda Özler
Judy Kesibi
Yasemin Gürsoy-Özdemir

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1041461

4,577 views
15 citations

Original Research

Published on 09 Jan 2023

Chronic Δ9-tetrahydrocannabinol impact on plasticity, and differential activation requirement for CB1-dependent long-term depression in ventral tegmental area GABA neurons in adult versus young mice

in Neuropharmacology

Isaac Ostlund
Michael Von Gunten
Calvin Smith
Jeffrey G. Edwards

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1067493

7,102 views
5 citations

Review

Published on 09 Jan 2023

Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics

in Neuropharmacology

Rodrigo Pérez-Arancibia
Marisol Cisternas-Olmedo
Denisse Sepúlveda
Paulina Troncoso-Escudero
Rene L. Vidal

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1084493

6,571 views
9 citations

Review

Published on 06 Jan 2023

Catecholaminergic and cholinergic neuromodulation in autism spectrum disorder: A comparison to attention-deficit hyperactivity disorder

in Neuropharmacology

Damian Koevoet
P. K. H. Deschamps
J. L. Kenemans

Frontiers in Neuroscience

doi 10.3389/fnins.2022.1078586

6,493 views
14 citations